Subcutaneous her2 antibody formulations
Fixed dose HER2 antibody formulations for subcutaneous administration are provided along with their use in the treatment of cancer. The formulations include fixed dose subcutaneous formulations of pertuzumab and subcutaneous co-formulations of pertuzumab and trastuzumab, and their use in the treatme...
Saved in:
| Main Authors | , , , , , , , , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
11.05.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Fixed dose HER2 antibody formulations for subcutaneous administration are provided along with their use in the treatment of cancer. The formulations include fixed dose subcutaneous formulations of pertuzumab and subcutaneous co-formulations of pertuzumab and trastuzumab, and their use in the treatment of cancer. |
|---|---|
| AbstractList | Fixed dose HER2 antibody formulations for subcutaneous administration are provided along with their use in the treatment of cancer. The formulations include fixed dose subcutaneous formulations of pertuzumab and subcutaneous co-formulations of pertuzumab and trastuzumab, and their use in the treatment of cancer. |
| Author | KIRSCHBROWN, WHITNEY ENG-WONG, JENNIFER KHAN, TARIK WURTH, CHRISTINE LIN, JASPER GARG, AMIT HEESON, SARAH ALAVATTAM, SREEDHARA BADOVINAC-CRNJEVIC, TANJA |
| Author_xml | – fullname: LIN, JASPER – fullname: ALAVATTAM, SREEDHARA – fullname: GARG, AMIT – fullname: KIRSCHBROWN, WHITNEY – fullname: WURTH, CHRISTINE – fullname: KHAN, TARIK – fullname: ENG-WONG, JENNIFER – fullname: HEESON, SARAH – fullname: BADOVINAC-CRNJEVIC, TANJA |
| BookMark | eNrjYmDJy89L5WRQDy5NSi4tScxLzS8tVshILTJSSMwryUzKT6lUSMsvyi3NSSzJzM8r5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8SHhnhYmhhYmlk5OxkQoAQBycipJ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | TWI841849BB |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_TWI841849BB3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Aug 30 05:42:17 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_TWI841849BB3 |
| Notes | Application Number: TW202110120880 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240511&DB=EPODOC&CC=TW&NR=I841849B |
| ParticipantIDs | epo_espacenet_TWI841849BB |
| PublicationCentury | 2000 |
| PublicationDate | 20240511 |
| PublicationDateYYYYMMDD | 2024-05-11 |
| PublicationDate_xml | – month: 05 year: 2024 text: 20240511 day: 11 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | F. HOFFMANN-LA ROCHE AG GENENTECH, INC |
| RelatedCompanies_xml | – name: F. HOFFMANN-LA ROCHE AG – name: GENENTECH, INC |
| Score | 3.6726258 |
| Snippet | Fixed dose HER2 antibody formulations for subcutaneous administration are provided along with their use in the treatment of cancer. The formulations include... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | BABY COMFORTERS CHEMISTRY CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY DEVICES FOR RECEIVING SPITTLE DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Subcutaneous her2 antibody formulations |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240511&DB=EPODOC&locale=&CC=TW&NR=I841849B |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVWl9kYPEUzCP3cQ9BCEvqmBbJNreSiYP2ostJkX01ztZEvWit2UXZncHvp35dndmAK4so0g5mqiZHG2N2VmiJbaTagwZEgPh3EGZ7XNkD5_Zw4zPOrBoY2FkntB3mRyREJUS3it5Xq9_LrEC-beyvMElda3uotgN1IYdk3kiB0INPDecjIOxr_q-G0_V0ZN7f8uIywhvC7bJiXZqLIQvXh2Tsv5tUKID2JmQrNfqEDqfix7s-W3dtR7sPjbP3dRskFcewTUhPN2QJ5cTVVdI0aZCOlniKvtQar-zqcJVHoMShbE_1GjG-ffm5vG0XZpnnUCXOH_eB4VoDBcW19PM4QzNPBG6JQrhIMt1FKIYwOBPMaf_jJ3Bfq2l-vnbMM6hW71t8guyqhVeSoV8AcdFfOM |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGQIwbDBDj2QMqp4o-kpYcKqS-1MHWTaiw3aqmD20XNtFOCH49btUCF7hFieQklr7YXxLbANeakieUq1xSKdcloqexFOtGIhFOODIQSg1eZ_sMdP-ZPMzpvAOLNhamzhP6XidHREQliPeyPq_XP5dYTv23srjlS-xa3Xuh6YgNO0bzhA6E6FimO504E1u0bTOcicGTObwjyGWYtQXb6GAbFRbcF6uKSVn_NijePuxMUdZreQCdz0UfenZbd60Pu-PmuRubDfKKQ7hBhCcb9OQypOoCKloVUCdLvko_hMrvbKpwFUcgeG5o-xLOGH1vLgpn7dIs7Ri6yPmzExCQxlCmUTlJDUq4msVM1ljODE4ymTOWD2Dwp5jTf8auoOeH41E0GgaPZ7BXaax6CleUc-iWb5vsAi1syS9r5XwBzXZ_1g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Subcutaneous+her2+antibody+formulations&rft.inventor=LIN%2C+JASPER&rft.inventor=ALAVATTAM%2C+SREEDHARA&rft.inventor=GARG%2C+AMIT&rft.inventor=KIRSCHBROWN%2C+WHITNEY&rft.inventor=WURTH%2C+CHRISTINE&rft.inventor=KHAN%2C+TARIK&rft.inventor=ENG-WONG%2C+JENNIFER&rft.inventor=HEESON%2C+SARAH&rft.inventor=BADOVINAC-CRNJEVIC%2C+TANJA&rft.date=2024-05-11&rft.externalDBID=B&rft.externalDocID=TWI841849BB |